A multicenter, randomized, double-blind study to evaluate the lipid-altering efficacy and safety of the ezetimibe/simvastatin combination tablet versus rosuvastatin in patients with primary hypercholesterolemia

Trial Profile

A multicenter, randomized, double-blind study to evaluate the lipid-altering efficacy and safety of the ezetimibe/simvastatin combination tablet versus rosuvastatin in patients with primary hypercholesterolemia

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Mar 2017

At a glance

  • Drugs Ezetimibe/simvastatin; Rosuvastatin
  • Indications Hypercholesterolaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 26 Jan 2010 Trial phase changed from II/II to III as reported by ClinicalTrials.gov.
    • 22 Dec 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top